Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial

Ophthalmology

Volumn 118, Issue 2, 2011, Pages 332-338

  Ying, Gui Shuang ^a   Maguire, Maureen G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUSEN; FOLLOW UP; GEOGRAPHIC ATROPHY; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY (TOPIC); NIGHT VISION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA DEGENERATION; RISK FACTOR; SCORING SYSTEM; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; GEOGRAPHIC ATROPHY; HUMANS; LASER COAGULATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; QUESTIONNAIRES; RETINAL DRUSEN; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; VISUAL ACUITY;

EID: 79551546627     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.06.030     Document Type: Article

References (34)

1. J.P. Sarks, S.H. Sarks, and M.C. Killingsworth Evolution of geographic atrophy of the retinal pigment epithelium Eye (Lond) 2 1988 552 577
2. Eye Diseases Prevalence Research Group Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 2004 564 572
3. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
4. P.J. Rosenfeld, D.M. Brown, J.S. Heier ANCHOR Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
5. W. Smith, J. Assink, and R. Klein Risk factors for age-related macular degeneration: pooled findings from three continents Ophthalmology 108 2001 697 704
6. R.H. Cong, B. Zhou, and Q.M. Su Smoking and the risk of age-related macular degeneration: a meta-analysis Ann Epidemiol 18 2008 647 656 (Pubitemid 352001387)
7. Age-Related Eye Disease Study Research Group Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19 Ophthalmology 112 2005 533 539
8. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS report no. 17 Arch Ophthalmol 123 2005 1484 1498
9. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group Risk factors for choroidal neovascularization and geographic atrophy in the Complications of Age-related Macular Degeneration Prevention Trial Ophthalmology 115 2008 1474 1479
10. G.S. Ying, M.G. Maguire, J. Alexander Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Prevention Trial Arch Ophthalmol 127 2009 1147 1151
11. J.S. Tan, P. Mitchell, and A. Kifley Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study Arch Ophthalmol 125 2007 1089 1095 (Pubitemid 47258039)
12. S.C. Tomany, J.J. Wang, and R. van Leeuwen Risk factors for incident age-related macular degeneration: pooled findings from 3 continents Ophthalmology 111 2004 1280 1287
13. R. Klein, B.E. Klein, S.C. Tomany, and K.J. Cruickshanks The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study Ophthalmology 110 2003 1273 1280
14. R. Klein, T. Peto, A. Bird, and M.R. Vannewkirk The epidemiology of age-related macular degeneration Am J Ophthalmol 137 2004 486 495
15. R. Klein, M.D. Knudtson, K.J. Cruickshanks, and B.E. Klein Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study Arch Ophthalmol 126 2008 115 121
16. J.M. Seddon, P.J. Francis, and S. George Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration JAMA 297 2007 1793 1800
17. J.R. Yates, T. Sepp, B.K. Matharu Genetic Factors in AMD Study Group Complement C3 variant and the risk of age-related macular degeneration N Engl J Med 357 2007 553 561
18. J.M. Seddon, R. Reynolds, and J. Maller Prediction model for prevalence and incidence of age-related macular degeneration based on genetic, demographic and environmental variables Invest Ophthalmol Vis Sci 50 2009 2044 2053
19. G.S. Ying, M.G. Maguire, C.C. Liu, A.N. Antoszyk Complications of Age-related Macular Degeneration Prevention Trial Research Group Night vision symptoms and progression of age-related macular degeneration (AMD) in the Complications of Age-related Macular Degeneration Prevention Trial Ophthalmology 115 2008 1876 1882
20. R.B. DAgostino Sr, S. Grundy, L.M. Sullivan CHD Risk Prediction Group Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation JAMA 286 2001 180 187
21. F.A. Medeiros, R.N. Weinreb, and P.A. Sample Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma Arch Ophthalmol 123 2005 1351 1360
22. Ocular Hypertension Treatment Study Group European Glaucoma Prevention Study Group Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension Ophthalmology 114 2007 10 19
23. F.A. Medeiros, and R.N. Weinreb Predictive models to estimate the risk of glaucoma development and progression Prog Brain Res 173 2008 15 24
24. Complications of Age-Related Macular Degeneration Prevention Trial Research Group The Complications of Age-Related Macular Degeneration Prevention Trial (CAPT): rationale, design and methodology Clin Trials 1 2004 91 107
25. Complications of Age-Related Macular Degeneration Prevention Trial Research Group Laser treatment in patients with bilateral large drusen: the Complications of Age-Related Macular Degeneration Prevention Trial Ophthalmology 113 2006 1974 1986
26. Age-Related Eye Disease Study Research Group A simplified severity scale for age-related macular degeneration: AREDS report no. 18 Arch Ophthalmol 123 2005 1570 1574
27. L.M. Sullivan, J.M. Massaro, and R.B. DAgostino Sr Presentation of multivariate data for clinical use: the Framingham Study risk score functions Stat Med 23 2004 1631 1660
28. B. Choi Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test Am J Epidemiol 148 1998 1127 1132
29. B. Efron, and R.J. Tibshirani An Introduction to the Bootstrap Monographs on Statistics and Applied Probability vol. 57 1993 Chapman and Hall London 168 177
30. D.J. Margolis, W. Bilker, and R. Boston Statistical characteristics of area under the receiver operating characteristic curve for a simple prognostic model using traditional and bootstrapped approaches J Clin Epidemiol 55 2002 518 524
31. G.W. Brier Verification of weather forecasts expressed in terms of probability Mon Weather Rev 78 1950 1 3
32. F.E. Harrell Jr, K.L. Lee, and D.B. Mark Multivariate prognostic models: issues in developing models, evaluating assumption and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
33. M.L. Klein, F.L. Ferris III, J. Armstrong AREDS Research Group Retinal precursors and the development of geographic atrophy in age-related macular degeneration Ophthalmology 115 2008 1026 1031
34. D.G. Altman, and P. Royston What do we mean by validating a prognostic model? Stat Med 19 2000 453 473